Dare Bioscience Inc (DARE)
0.3112
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.3112
0.00 (0.00%)
After-Hours: 20:00
Dare Bioscience Total Assets (Quarterly): 21.28M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 21.28M |
| September 30, 2023 | 25.05M |
| June 30, 2023 | 23.21M |
| March 31, 2023 | 30.37M |
| December 31, 2022 | 43.83M |
| September 30, 2022 | 50.38M |
| June 30, 2022 | 51.39M |
| March 31, 2022 | 49.19M |
| December 31, 2021 | 55.81M |
| September 30, 2021 | 48.81M |
| June 30, 2021 | 14.82M |
| March 31, 2021 | 10.52M |
| December 31, 2020 | 7.551M |
| September 30, 2020 | 7.662M |
| June 30, 2020 | 8.570M |
| March 31, 2020 | 10.21M |
| December 31, 2019 | 7.443M |
| September 30, 2019 | 3.882M |
| June 30, 2019 | 7.261M |
| March 31, 2019 | 5.020M |
| December 31, 2018 | 7.827M |
| Date | Value |
|---|---|
| September 30, 2018 | 10.80M |
| June 30, 2018 | 13.48M |
| March 31, 2018 | 16.63M |
| December 31, 2017 | 14.26M |
| September 30, 2017 | 23.27M |
| June 30, 2017 | 8.151M |
| March 31, 2017 | 15.95M |
| December 31, 2016 | 0.0446M |
| September 30, 2016 | 40.13M |
| June 30, 2016 | 49.89M |
| March 31, 2016 | 63.02M |
| December 31, 2015 | 78.22M |
| September 30, 2015 | 80.12M |
| June 30, 2015 | 88.10M |
| March 31, 2015 | 59.38M |
| December 31, 2014 | 53.39M |
| September 30, 2014 | 60.09M |
| June 30, 2014 | 65.74M |
| March 31, 2014 | 11.85M |
| December 31, 2013 | 6.827M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.882M
Minimum
Sep 2019
55.81M
Maximum
Dec 2021
25.12M
Average
21.28M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Altimmune Inc | 210.64M |
| Verastem Inc | 149.72M |
| Oragenics Inc | 4.966M |
| Actinium Pharmaceuticals Inc | 88.35M |
| Orgenesis Inc | 14.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.33M |
| Shareholders Equity (Quarterly) | -5.048M |
| Current Ratio | 0.8566 |